Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eli L Diamond

Showing results (21-30 of 130) with videos related to

Pageof 13
Sort By:
Blood Advances|January 9, 2025
Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot studyFrancesco Pegoraro, Francesco Catamerò, Federica Allegretta, et al.
Neuro-Oncology Practice|August 7, 2019
Existential distress among caregivers of patients with brain tumors: a review of the literatureAllison J Applebaum, Maria Kryza-Lacombe, Justin Buthorn, et al.
American Journal of Ophthalmology Case Reports|September 3, 2020
Necrotizing myositis in a rectus muscle arising in the setting of long-standing Langerhans cell histiocystosis and recent dabrafenib treatmentSuzanne W van Landingham, Diane Puccetti, Heather Potter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 4, 2020
Erdheim-Chester disease among neuroinflammatory syndromes: the case for precision medicineMacarena I de la Fuente, Marc K Rosenblum, Eli L Diamond, et al.
Pediatric Dermatology|December 22, 2021
Progressive nodular histiocytosis in a 9-year-old boy treated with cobimetinibMaría Marta Buján, Cristian Sánchez La Rosa, María Laura Galluzzo Mutti, et al.
Ocular Oncology and Pathology|June 9, 2020
MEK Inhibitor-Associated Central Retinal Vein Occlusion Associated with Hyperhomocysteinemia and MTHFR VariantsJasmine H Francis, Eli L Diamond, Ping Chi, et al.
Histopathology|February 27, 2026
CD71 expression in Rosai-Dorfman disease: a useful adjunct marker in the differential diagnosis of histiocytic proliferationsNurfiza N Ladak, Kseniya Petrova-Drus, Meera R Hameed, et al.
World Neurosurgery|August 29, 2018
Letter to the Editor Regarding "National Trends for Reoperation in Older Patients with Glioblastoma"Anne S Reiner, Debra A Goldman, Eli L Diamond, et al.
Ophthalmology Science|July 29, 2024
Plasma-Derived Cell-Free DNA for the Diagnosis of Ocular-Involving HistiocytosisJasmine H Francis, Maria E Arcila, Allison Sigler, et al.
Neuro-Oncology Advances|January 28, 2021
Lack of survival advantage among re-resected elderly glioblastoma patients: a SEER-Medicare studyDebra A Goldman, Anne S Reiner, Eli L Diamond, et al.
Pageof 13

Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
Blood Advances|January 9, 2025
Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot studyFrancesco Pegoraro, Francesco Catamerò, Federica Allegretta, et al.
Neuro-Oncology Practice|August 7, 2019
Existential distress among caregivers of patients with brain tumors: a review of the literatureAllison J Applebaum, Maria Kryza-Lacombe, Justin Buthorn, et al.
American Journal of Ophthalmology Case Reports|September 3, 2020
Necrotizing myositis in a rectus muscle arising in the setting of long-standing Langerhans cell histiocystosis and recent dabrafenib treatmentSuzanne W van Landingham, Diane Puccetti, Heather Potter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 4, 2020
Erdheim-Chester disease among neuroinflammatory syndromes: the case for precision medicineMacarena I de la Fuente, Marc K Rosenblum, Eli L Diamond, et al.
Pediatric Dermatology|December 22, 2021
Progressive nodular histiocytosis in a 9-year-old boy treated with cobimetinibMaría Marta Buján, Cristian Sánchez La Rosa, María Laura Galluzzo Mutti, et al.
Ocular Oncology and Pathology|June 9, 2020
MEK Inhibitor-Associated Central Retinal Vein Occlusion Associated with Hyperhomocysteinemia and MTHFR VariantsJasmine H Francis, Eli L Diamond, Ping Chi, et al.
Histopathology|February 27, 2026
CD71 expression in Rosai-Dorfman disease: a useful adjunct marker in the differential diagnosis of histiocytic proliferationsNurfiza N Ladak, Kseniya Petrova-Drus, Meera R Hameed, et al.
World Neurosurgery|August 29, 2018
Letter to the Editor Regarding "National Trends for Reoperation in Older Patients with Glioblastoma"Anne S Reiner, Debra A Goldman, Eli L Diamond, et al.
Ophthalmology Science|July 29, 2024
Plasma-Derived Cell-Free DNA for the Diagnosis of Ocular-Involving HistiocytosisJasmine H Francis, Maria E Arcila, Allison Sigler, et al.
Neuro-Oncology Advances|January 28, 2021
Lack of survival advantage among re-resected elderly glioblastoma patients: a SEER-Medicare studyDebra A Goldman, Anne S Reiner, Eli L Diamond, et al.
Pageof 13